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Abstract
We demonstrate the first application of synthetic RNA gene silencers in Streptomyces coelicolor A3(2). Peptide nucleic acid
and expressed antisense RNA silencers successfully inhibited actinorhodin production. Synthetic RNA silencing was target-
specific and is a new tool for gene regulation and metabolic engineering studies in Streptomyces.
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Introduction
Bacteria use endogenous transcripts to help regulate a diverse
range of cellular processes. These RNAs include riboswitches
(mRNA leaders that affect transcription in cis), protein-binding
small RNAs, CRISPR RNAs (involved in the targeting and
degradation of foreign DNA) and both cis- and trans-encoded
mRNA-binding sRNAs [1]. The application of computational
searches in combination with RNA sequencing has enabled
prediction of hundreds of putative regulatory RNAs in multiple
species; the verified sRNAs of Escherichia coli account for < 2% of
its identified genes [2]. Regulatory RNAs can act as repressors or
activators of transcription, or as stabilizers of target transcripts,
and are involved in a wide variety of cellular processes including
virulence regulation, quorum sensing, stress responses and
secretion [3].
The genus Streptomyces includes species that have complex
genetic regulatory pathways, in part due to a need for
morphological differentiation and the production of diverse
bioactive secondary metabolites, including the majority of known
antibiotics [4]. The biotechnological importance of this genus
makes advances in the understanding and manipulation of
regulatory RNAs of interest. Accordingly, bioinformatics [5,6,7]
and deep-sequencing [8] have been applied to identify putative
small RNAs in the genomes of Streptomyces species. In a recent
study, D’Alia et al. [9] were the first to elucidate the regulatory
effect of a cis-encoded antisense sRNA, cnc2198.1 in glutamine
synthetase I. Expression of cnc2198.1 in Streptomyces coelicolor A3(2)
resulted in decreased growth, reduced protein production and
synthesis of the red-pigmented antibiotic, undecylprodigiosin. A
second example of a cis-encoded sRNA a-abeA was identified in S.
coelicolor as part of a four-gene cluster involved in the enhanced
production of the blue-pigmented antibiotic, actinorhodin,
although the exact role of a-abeA has yet to be elucidated [4,6].
Trans-encoded sRNAs are analogous to eukaryotic miRNAs, and,
in many cases, require an RNA chaperone to mediate regulation
[1]. In vitro and in silico evidence of a trans-encoded antisense sRNA
micX, a putative activator of actinorhodin biosynthesis, has been
reported [10,11] with a recent study providing in vivo evidence for
a S. coelicolor trans-encoded sRNA (scr5239) acting as a repressor of
extracellular agarase expression [12]. Both cis- and trans-encoded
sRNAs are thought to regulate gene expression as antisense RNA
silencing molecules (asRNAs) that bind to their mRNA target,
inhibit ribosome access and/or trigger mRNA degradation [13].
The studies cited above demonstrate that Streptomyces species use
sRNAs to regulate gene expression; as such it is attractive to
consider ways to exploit these molecules in practical applications.
The use of conditional antisense RNA silencing may be of use not
only in the elucidation of secondary metabolite regulation, but also
in studies where gene knockouts are unsuitable e.g. when
monitoring the affect of transcript abundance on gene expression;
determining the minimally required levels of expression of essential
genes [14]; and where the physical structure of the chromosome is
related to transcriptional activity [15]. Synthetic RNA silencing,
here defined as the use of antisense sequences that are either non-
biological in origin or trans-acting RNAs that are not naturally
expressed by the host, has yet to be demonstrated in the genus
Streptomyces. Oligo-nucleobase antisense RNA silencers, such as
peptide nucleic acid (PNA) and phosphorodiamidate morpholino
oligomers (PMO), are DNA mimics that maintain naturally
occurring DNA bases but have non-natural linkages between
bases. PNAs and PMOs, conjugated to peptide carrier molecules,
have been used to silence gene expression in a number of Gram-
positive and Gram-negative species [16,17,18], and have the
advantage of being resistant to biological degradation and do not
require genetic transformation for delivery; carrier peptides
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attached to the PNA mediate delivery across the cell wall/
membrane. Expressed RNAs designed to hybridize to target
mRNA have been applied successfully in both Gram-positive and
Gram-negative species, with Gram-positive species initially yield-
ing more consistent gene silencing [19]. Recently, the addition of
paired-termini (antisense RNA flanked by inverted repeats) proved
successful in improving the efficacy of antisense RNA gene
silencing in E. coli, most likely through the stabilization, and
thereby increased abundance, of the asRNA [20].
In this study, we demonstrate, for the first time, the successful
application of synthetic RNA silencing in Streptomyces. Both
peptide-PNA conjugants and paired-termini antisense RNA were
used to silence the expression of a gene required for actinorhodin
biosynthesis. The development of antisense RNA gene silencers for
Streptomyces species provides complementary tools to conventional
genetics for the elucidation of regulatory pathways and gene
function and will be a valuable tool in metabolic engineering.
Results and Discussion
Peptide-PNA Gene Silencing of actI-ORF1
To investigate the use of synthetic RNA gene silencers, we
targeted the actinorhodin polyketide beta-ketoacyl synthase
subunit gene (actI-ORF1). Two peptide-PNAs (Sc001 and Sc002)
were designed and applied as antisense agents targeting the
translation initiation region of actI-ORF1 (Fig. 1A). Guidelines for
the design of peptide-PNA antisense gene silencers have been
reported elsewhere [21,22]. In this study we used 9 bp PNAs as
they are reported to have improved uptake properties; longer
PNAs also have an increased risk for non-target binding and self-
complementarity [35]. In PNAs of 10–15 bp, mismatches with the
target of .2 bp abolish activity, while mismatches of 1 bp abolish
or significantly reduce activity. Thus, for the PNAs used in this
study, it is likely that only genes with perfect matches in the target
region will be significantly repressed. We identified all potential
off-target genes for Sc001 and Sc002 (19 and 33 targets,
respectively [Table S1 information]), none of which are predicted
to have a role in antibiotic synthesis (many are annotated as
possible or hypothetical proteins). For Sc001 only the intended
target has a perfect match with the PNA, while Sc002 matches the
target and SCO6703, a gene predicted to encode a putative 3-
oxoacid CoA-transferase that is possibly involved in aromatic acid
degradation. While a role for SCO6703 in actinorhodin produc-
tion cannot be ruled out, it is unlikely that repression of this gene
would play a significant role in the peptide-PNA mediated
silencing of actinorhodin biosynthesis (Sc001 has 4 bp mismatches
with the TIR of SCO6703 and results in a similar phenotype to
Sc002). Actinorhodin production was clearly inhibited at 50 mM
for both Sc001 and Sc002, but not by a scrambled peptide-PNA
(Fig. 1B). The viability of subcultures taken from the area of
peptide-PNA application and the lack of inhibition by the
scrambled peptide-PNA indicates that the silencing of actinorho-
din production was due to gene silencing and not growth
inhibition. Experiments using ISP-4 agar medium indicated that
neither PNA affected production of undecylprodigiosin (Fig. 1C).
These results show that S. coelicolor is accessible to synthetic RNA
silencing. Furthermore, susceptibility to PNA mediated gene
silencing suggests that other RNA silencing strategies may also
be effective in this genus. As PNA synthesis is relatively expensive,
we also evaluated synthetic RNA silencing in S. coelicolor using
expressed antisense RNA.
Expressed Antisense RNA Silencing of actI-ORF1
DNA sequences (120–160 bp) covering the 59UTR, RBS and
.50 bp of the coding region of actI-ORF1 were examined as
potential antisense RNAs. Sequences with low secondary struc-
ture, and high positional entropy in the mRNA binding portion of
the asRNA, were identified using RNAfold [23] (Fig. 2). A 155 bp
region (-92 to +63) with the desired features was PCR-amplified
from S. coelicolor MT1110 gDNA using primers with 21 bp
inverted repeat overhangs, designed to generate antisense RNA
transcripts with paired termini (PTasRNA) [20]. This amplicon
was cloned into integrative pIJ8600 [24] and replicative pSH19
[25] vectors to form pAS01 and pAS02, respectively. Both pAS01
and pAS02 were used to transform S. coelicolor MT1110 and
actinorhodin production was monitored in a number of media.
For liquid and agar R5 media, both S. coelicolor MT1110/pAS01
and pAS02 showed visible reduction of actinorhodin production
when induced with thiostrepton and e–caprolactam, respectively
(Fig. 3). In liquid culture, actinorhodin production was clearly
reduced in non-induced MT1110/pAS02 indicating that, in our
hands, expression of antisense RNA from vector pSH19 was likely
to occur in the absence of induction. For this reason, pAS02 was
excluded from further analysis.
Quantification of the Effects on Antibiotic Production
To determine whether RNA silencing using PTasRNA was
specific to actI-ORF1, growth and antibiotic production were
monitored for MT1110/pAS01 and control cultures in R5 liquid
medium (Fig. 4). In all cases, growth and the production of
undecylprodigiosin was equivalent to that of uninduced S. coelicolor
MT1110, indicating that expression of the antisense RNA was not
growth inhibitory, and that reduced antibiotic production was
restricted to actinorhodin biosynthesis (production of the calcium-
dependent antibiotic was also unaffected by antisense RNA
production, Figure S2). In contrast, induced MT1110/pAS01
displayed unaltered growth but < 4-fold reduced actinorhodin
production; 10 mM for induced cultures, compared to .40 mM
for uninduced MT1110/pAS01 and other controls after 7 days
incubation (Fig. 4).
Quantification of the Effect on actI-ORF1 Transcription
To confirm that the asRNA was reducing actinorhodin
biosynthesis through a transcript silencing mechanism, RT-PCR
and qRT-PCR were employed to monitor expression of actI-
ORF1 mRNA (Fig. 5). RT-PCR analysis confirmed earlier
experiments, with only induced MT1110/pAS01 showing a
decrease in the abundance of actI-ORF1 mRNA. Primers
targeting the 59 end of the transcript yielded less amplification
product than those hybridising towards the 39 end (Fig. 5A).
Assuming equal primer access and amplification kinetics, this is
empirical evidence for the mRNA/asRNA hybrid being degraded
in the 59 –39 direction triggered by hybridization of the asRNA.
qRT-PCR analysis of replicate RNA extracts from 3-d-old cultures
was carried out with SCO4742 as the internal reference and values
were calculated relative to the expression levels of uninduced
MT1110. Consistent with antibiotic assays and RT-PCR data,
only induced MT1110/pAS01 showed a significant difference (<
5-fold decrease) in the level of actI-ORF1 expression (Fig. 5B).
Conclusions/Concluding Remarks
In this study we have demonstrated that synthetic asRNA can
be designed and used to regulate gene expression in S. coelicolor.
Furthermore, RNA silencing was effective when expressed from
either the chromosome or from a replicative plasmid. The
Synthetic RNA Silencing in Streptomyces coelicolor
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application of antisense RNA silencing in the genus Streptomyces
provides a complimentary tool to those of standard genetics and
is applicable in instances where gene knockouts are not suitable
(see above). This genus is responsible for the production of a
large number of high value compounds and the development of
techniques for improving titre through metabolic engineering
are industrially significant [26]. Antisense RNA silencing is of
particular value in the field of metabolic engineering since it can
avoid problems associated with lethal mutations caused by gene
knockouts; the level of silencing is variable and complete
inhibition of protein production can be avoided [27,28]. We
applied RNA silencing to inhibit production of an antibiotic,
however as earlier studies with natural asRNAs have shown
[10,11], it is possible that these methods could be used to
induce expression of silent biosynthetic gene clusters by silencing
repressors, or by interfering with mRNA secondary structures
that sequester ribosome binding sites [1]. Comparison of the
natural micX asRNA with that of the synthetic asRNA designed
for this study revealed possible areas for the future development
of asRNAs for use in Streptomyces: The micX asRNA has a
predicted paired-end structure that contains regions of non-
complementary nucleotides (Fig. 2); in E. coli these regions have
been shown to protect antisense RNAs from RNase III cleavage
[29]. Furthermore, as with other natural trans-encoded antisense
RNAs, the mRNA binding region of micX is < 25 bp. The
paired-termini approach used in this study has been applied
successfully using mRNA binding regions ,30 bp (Nobutaka
Nakashima, AIST Sapporo, personal communication) and thus
the design of synthetic asRNAs based on naturally occurring
trans-encoded asRNAs may yield more effective gene silencers. It
is also likely that a better understanding of the mechanism of
antisense RNA gene silencing in Streptomyces will lead to
improvements in asRNA design. For example, in many species,
limited complementarity between natural trans-encoded asRNAs
and the corresponding mRNA requires the RNA chaperone
Hfq to facilitate RNA-RNA interactions [30]. Hfq is believed to
protect asRNAs from degradation when they are not bound to
their target mRNAs, and to recruit the RNA degradation
machinery once the asRNA is paired to the target mRNA. [1]
There are no obvious homologues of Hfq in the genome of S.
coelicolor [9] and it remains to be determined whether an RNA
chaperone is required for asRNA gene silencing in Streptomyces.
Long stretches of base pairing, or high concentrations of the
asRNA, as in the case of the synthetic asRNAs used in this
study, may obviate a chaperone requirement [1]. However,
scr5239, a trans-encoded sRNA repressor of extracellular agarase
expression, has five stem-loop structures that presumably require
facilitated opening in order for annealing to occur, leading the
authors to speculate that Streptomyces species may require
proteins to carry out the functions of Hfq [12]. Consequently,
the identification of such an RNA chaperone in Streptomyces
could aid in the development of synthetic asRNAs since
synthetic RNAs could then be designed to mimic naturally
occurring trans-acting sRNAs. The use of peptide-PNAs in
Streptomyces is of particular interest as genetic transformation is
not required for gene silencing, thus they can be used in species
Figure 1. RNA silencing using peptide-PNA. (A) Schematic diagram representing the binding site of antisense peptide-PNAs designed to
prevent transcription of actI-ORF1. The start codon of actI-ORF1 is shown in bold, the putative Shine-Dalgarno site in red. Sc001 and Sc002 differ in
the degree of coverage of the start codon. (B) Demonstration of the ability of peptide-PNAs to silence production of actinorhodin in S. coelicolor.
Peptide-PNA solutions were applied to a lawn of S. coelicolor (after 24 hrs) on MPCA agar and incubation continued for a further 72 hrs. Repression of
actinorhodin production is clearly visible with 50 mM treatment using either Sc001 or Sc002; no reduction in actinorhodin production was evident
when a scramble-PNA with limited complementarity to the S. coelicolor genome was used at the same concentration. (C) Peptide-PNA solutions were
applied directly to a lawn of S. coelicolor MT1110 on ISP-4 agar and were photographed from on top (left) and from bottom (right) after 96 hrs
incubation at 28uC.
doi:10.1371/journal.pone.0067509.g001
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Figure 2. Predicted secondary structures of antisense RNAs. Secondary structure of (A) the paired-termini antisense actI-ORF1 asRNA (292 to
+63 bp) designed in this study for silencing of actinorhodin production, and (B) micX, a naturally occurring trans-encoded antisense RNA from
Synthetic RNA Silencing in Streptomyces coelicolor
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in which genetic tools have not been established or to simply
accelerate the process of genetic analysis. The current synthesis
costs and high concentrations required when using these
molecules in agar-based assays makes optimization studies
prohibitive. However, improvements in micro-culture of Strepto-
myces [31] and reduced synthesis costs will enable different
peptide-PNA designs to be evaluated for this genus. In
summary, recent reports reveal that Streptomyces use endogenous
transcripts to regulate gene expression, and here we show for
the first time that synthetic strategies using expressed RNA or a
delivered DNA mimic can provide useful levels of RNA
silencing. As a method, RNA silencing can be used to improve
our understanding of Streptomyces biology and possibly alter
metabolic flux in industrial applications.
Materials and Methods
Bacterial Strains, Plasmids and Culture Conditions
The strains and plasmids used in this study are listed in Table 1.
Standard media and conditions for growth were as previously
described [24,32]. The media were supplemented with the
following chemicals when required: 100 mg/ml ampicillin (Amp),
50 mg/ml kanamycin (Kan), 25 mg/ml chloramphenicol (Chl),
25 mg/ml nalidixic acid (Nal), 50 mg/ml apramycin (Apr), 25 (or
50) mg/ml thiostrepton (Tsr) and 0.1% (wt/vol) e-caprolactam.
Growth in liquid R5 was monitored by optical density (A430).
Antibiotic Assays
Spores (36106 colony forming units [CFU]) of the experimental
and control strains were inoculated into 20 ml of R5 liquid
medium containing the appropriate antibiotics to an OD450 of <
0.05. Cultures were grown for 18 h before 1 ml was transferred to
50 ml of R5 liquid medium containing appropriate antibiotics and
Streptomyces lividans involved in the activation of actinorhodin biosynthesis. The micX asRNA has a predicted paired-end structure which suggests
that the synthetic strategy followed in this study (addition of paired termini to antisense RNA) may be analogous to natural antisense mechanisms in
Streptomyces. micX also contains non-complementary nucleotide sequences in the paired region which may serve to protect antisense RNAs from
RNase III cleavage.
doi:10.1371/journal.pone.0067509.g002
Figure 3. Actinorhodin production in S. coelicolor MT1110 and effects of RNA silencing. (A) MT1110/pAS01 after 6 days of growth in R5
liquid medium (top panels, the region shown is represented by the flask on the right) and R5 agar (bottom panels) containing thiostrepton (+
induction) or DMSO (- induction). MT1110/pIJ8600 served as a control. (B) As above with MT1110/pAS02, e-caprolactam as the inducer of expression
and MT1110/pSH19 as the control.
doi:10.1371/journal.pone.0067509.g003
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inducers (for induction samples). Actinorhodin and undecylprodi-
giosin samples from three biological replicates were quantified
according to standard protocols [24,33]. Production of the
calcium-dependent antibiotic was assayed using Bacillus mycoides
ATCC 6462 as an indicator strain [34].
Peptide Nucleic Acid (PNA) RNA Silencing of actI-ORF1
Sc001 and Sc002, antisense PNAs specific for actI-ORF1, were
designed using previously described parameters [16,35] and
differed in their degree of coverage of the start codon of actI-
ORF1. A scrambled PNA that had no sites of perfect comple-
mentarity in the genome of S. coelicolor MT1110 was used as a
negative control (see Table 2 for PNA sequences). The cell-wall
permeating peptide (KFF)3K, was attached to the N-terminus of
each PNA (which corresponds to a 59 nucleic acid terminus) via a
flexible ethylene glycol linker [16]. Peptide-PNAs were synthesized
as previously described [14]. Fifty microlitres of a S. coelicolor
MT1110 spore suspension (1.56108 CFU/mL) were used to
prepare a confluent lawn of growth (24 h incubation at 28uC) on
MPCA agar plates (yeast extract, 0.2%, meat extract 0.2%, Bacto-
peptone 0.4%, NaCl 0.5%, MgSO4.7H2O 0.2%, glycine 0.5%,
glucose 1.0%, sucrose 10%, casamino acid 0.01%, TES buffer
0.573% and agar 2%). Peptide-PNAs were applied directly to the
lawn at concentrations of 1, 10 and 50 mM and incubation
continued at 28uC for 72 hrs. To determine whether inhibition of
actinorhodin production was due to RNA silencing of actI-ORF1
or to non-specific toxicity of the PNAs, subcultures from the zones
of application were inoculated onto MPCA agar plates. ISP-4 agar
(inorganic salts-starch; Difco) that supports both undecylprodigio-
sin and actinorhodin production in S. coelicolor MT1110 was used
to evaluated the specificity of gene silencing: agar plates were
overlaid with 0.5% ISP-4 agar containing 2.36106 CFU/mL S.
coelicolor MT1110 spores, 10 mL of PNAs (50 mM) were applied to
antibiotic assay discs (Whatman) and placed onto the soft agar.
After 96 hours of incubation, the disks were removed and the agar
plates were photographed.
Construction of Antisense RNA Expressing Vectors
A 155 bp fragment (292 to +63 bp of the actI-ORF1 gene) was
amplified from S. coelicolor MT1110 gDNA using primers modified
to include paired-termini sequences [20]. Primers ac-
tIPT1HindSph-F and actIPT1EcoRPst-R were used for cloning
into pSH19. Primers actIPT1NdeSph-F and actIPT1XbaPst-R
were used for cloning into pIJ8600 (see Table 2 and Figure S1).
Primers contained SphI and PstI restriction sites for convenient
excision and replacement of the antisense RNA expressing
fragment of the vectors.
DNA Cloning and Bacterial Transformation and
Streptomyces Conjugation
DNA manipulations, E. coli transformations and Streptomyces
conjugations were carried out according to standard protocols
[24,32].
RNA Extraction from Streptomyces Strains
RNA was extracted from Streptomyces strains grown in liquid R5
medium (as above) using a modified Kirby mix, phenol/
chloroform extraction and DNAse I treatment [24]. RNA samples
were further purified using RNeasy columns according to the
manufacturer’s instructions (Qiagen, UK).
Figure 4. Antisense mediated decrease in actinorhodin pro-
duction. S. coelicolor MT1110 strains were grown in R5 liquid medium
containing thiostrepton (+ induction) or DMSO (- induction) for 5 days.
(A) Cell growth, and (B) undecylprodigiosin production were similar in
all cases. (C) Actinorhodin production was reduced when antisense RNA
was induced (MT1110/pAS01+). The data represent the average of three
independent determinations.
doi:10.1371/journal.pone.0067509.g004
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RT-PCR and qRT-PCR
RT-PCR was performed using the Promega Access RT-PCR
system with 400 ng RNA per sample. The RT-PCR conditions
were as follows: for cDNA synthesis, 45uC for 45 min, followed by
94uC for 2 min. For PCR amplification, 20 cycles at 94uC for 30 s,
55uC for 1 min, and 68uC for 2 min and 1 cycle at 68uC for
10 min. Two primer pairs (actIORF1258f/actIORF1497r and
actIORf1860f/actIORF11148r) were used to amplify distinct
regions of the actI-ORF1 mRNA. SCO4742 a hypothetical gene
that shows little variation in expression [36,37] was used as an
internal reference (see Table 2 for primer sequences). Negative
control experiments were run for each pair of primers in the
Figure 5. Effect of expressed antisense RNA on actI-ORF1 mRNA levels. RT-PCR of actI-ORF1 from RNA extracted from MT1110 strains grown
for 3 days in R5 liquid medium that contained thiostrepton (+) or DMSO (-) as a control. Two primers sets (top and middle panel) designed to amplify
different regions of the actI-ORF1 mRNA were used, with SCO4742 (bottom panel) serving as an internal control. M= 100 bp DNA ladder. (B) qRT-PCR
of actI-ORF1; SCO4742 served as the internal reference and expression was calculated relative to uninduced MT1110. Error bars represent standard
error for biological replicates (n= 3 ** highly significant difference, one way ANOVA, F=11.96, p =,0.01).
doi:10.1371/journal.pone.0067509.g005
Table 1. Bacterial Strains and plasmids used in this study.
Strain or plasmid Description Source or reference
Streptomyces coelicolor MT1110 Wild-type prototrophic; SCP12, SCP22 derivative of Streptomyces
coelicolor A3(2)
[24]
Escherichia coli DH5a For cloning and propagation of host strain, recA1 endA1 gyrA96 thi-1
hsdR17 supE44 relA1 lac [F’ proAB lacIqZDM15 Tn10 (Tetr)]
Stratagene
E. coli ET12567 dam dcm hsdS hsdR Chlr Kanr; carrying plasmid pUB307 [39]
Bacillus mycoides ATCC 6462 As an indicator organism for bioassay of calcium-dependent antibiotic American Type Culture Collection
pGEMT-Easy Ampr; E. coli vector for cloning PCR products Promega
pUB307 RP1 derivative contains oriT from IncP-group plasmid RK2 [39]
pIJ8600 Aprr Tsr tipAp; thiostrepton inducible integrative expression vector [24]
pSH19 Tsrr PnitA; replicative expression vector [25]
pAS01 Aprr Tsrr; 155 bp (-92 to +63) of actI-ORF1. Cloned in antisense orientation
into pIJ8600
This study
pAS02 Aprr Tsrr; 155 bp (-92 to +63) of actI-ORF1. Cloned in antisense orientation
into pSH19
This study
doi:10.1371/journal.pone.0067509.t001
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absence of reverse transcriptase (but with DNA polymerase
present). qRT-PCR was done using a Brilliant II SYBRH Green
QRT-PCR Master Mix 1-step kit (Agilent). Amplification and
analysis were performed on a Bio-Rad iCycler. Each 20-ml
reaction contained 500 ng RNA template, 1 mM each of
actIORf1860f and actIORF11148r, 10 ml 2x Master mix and
1 ml of reverse transcriptase enzyme mix (containing RNase
inhibitor). The qRT-PCR conditions were as follows: 1 cycle of
50uC for 30 min (reverse transcription), followed by another 1
cycle of 95uC for 10 min (to activate the DNA polymerase), then
40 cycles of 95uC for 30 s, 50uC for 30 s, 72uC for 1 min. An
additional 1 cycle at 72uC for 5 min was performed. SCO4742
was used as the internal standard. Estimation of the relative
amounts of transcript in each sample and the statistical calcula-
tions were as described [34] with the following modifications: a
standard curve was obtained with a set of sonicated serially diluted
genomic DNA positive controls. The amplification efficiency was
calculated by taking the gradient of the line of best fit through plots
of log10 dilution factors against the Ct values. The efficiency was
corrected based on multiple samples [38]. Negative controls were
as above.
Supporting Information
Figure S1 Schematic representation of the cloning
strategy used to construct antisense RNA expressing
vector pAS02.
(TIFF)
Figure S2 Calcium-dependent antibiotic assay. The assay
was performed as previously reported [34] using B. mycoides as the
indicator strain (A) wild-type S. coelicolor MT1110. (B) MT1110/
pAS01 induced by adding thiostrepton to the agar. Plates were
photographed and half images from each strain were aligned to
compare the size of the zone of inhibition.
(PNG)
Table S1 Off-target matches in S. coelicolor for PNAs
used in this study.
(DOCX)
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